Moreover, (R)-crizotinib alone or with CDDP induced PD-1 expression on tumor-infiltrating CD4+ Foxp3− but not in CD4+Foxp3+ (Treg) cells bearing the exhaustion marker ICOS (Fig. 6m, n). Here, ICOS is linked to neoplasm.